
| Attribute | Value | Date |
|---|---|---|
| PE ratio | -12.23 | 21/05/12 |
| EPS (Rs) | -0.98 | Mar, 12 |
| Sales (Rs crore) | 31.75 | Mar, 12 |
| Face Value (Rs) | 10 | |
| Net profit margin (%) | 2.23 | Mar, 11 |
| Last dividend (%) | 7.5 | 13/08/10 |
| Return on average equity | 14.04 | Mar, 11 |
| 15 May | Limited Review for March 31, 2012
| |
| 15 May | Financial Results for March 31, 2012
| |
| 29 Mar | Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
| |
| 14 Mar | Board Meeting on Mar 21, 2012 | |
| 11 Feb | Limited Review for Dec 31, 2011
| |
| 11 Feb | Financial Results for Dec 31, 2011
| |
| 10 Dec 2011 | ANVISA Brazil approval | |
| 03 Dec 2011 | Resignation of Directors | |
| 15 Nov 2011 | Financial Results for Sep 30, 2011
| |
| 25 Oct 2011 | Demise of Director | |
Thank you. Your call will appear shortly. Your returns will be updated at the end of the trading day. View All Calls